The economic impact of pharmacist care for people living with HIV/AIDS: A systematic review

Ali Ahmed, Juman Abdulelah Dujaili, Furqan Khurshid Hashmi, Ahmed Awaisu, Nathorn Chaiyakunapruk, Syed Shahzad Hasan

Research output: Contribution to journalReview articlepeer-review

Abstract

Background and objective
There is an increase in the global prevalence of the human immunodeficiency virus (HIV). While it has been proven that pharmacist interventions improve the health outcomes of people living with HIV/AIDS (PLWHA), the economic impact of these initiatives is uncertain. Consequently, we aim to systematically review and synthesize the evidence surrounding the economic impact of pharmacist care in PLWHA.

Methods
PubMed, EMBASE, Scopus, IPA via ProQuest, the Cochrane Library, and the CINAHL Plus databases were systematically searched. Original studies evaluating the economic effect of pharmacist-managed services for PLWHA were included in the review. The quality of the economic studies was assessed using the Consolidated Health Economic Evaluation Reporting Standard (CHEERS) checklist.

Results
A search of databases yielded 4206 citations, four of which met the eligibility criteria. Three studies were conducted in a hospital-based outpatient facility, while one study was conducted in a community pharmacy setting. The types of “pharmacist-managed services” included targeted motivational education, pharmaceutical care, health screening for opportunistic infections, and referral to specialists. Two of the four economic evaluation studies had complete economic analyses and were rated as moderate in quality. In comparison with usual care, pharmacist services led to cost savings of (51.29 to 165.74 in 2021 USD$) per person per year, saving 18.5 h per patient per year, and a lower cost of generating 12 years of quality-adjusted life years. In addition, the benefit-to-cost ratio of the pharmacist service was 2.51:1.

Conclusions
The pharmacist-managed services demonstrated the benefits of improving overall PLWHA health outcomes in economic viability. However, future real world controlled, high-quality economic studies are required to determine the long-term cost-effectiveness of these services, given the pharmacist's growing role in the health care team managing PLWHA.
Original languageEnglish
Article number100066
Number of pages8
JournalExploratory Research in Clinical and Social Pharmacy
Volume3
Early online date30 Aug 2021
DOIs
Publication statusPublished - 1 Sep 2021

Fingerprint

Dive into the research topics of 'The economic impact of pharmacist care for people living with HIV/AIDS: A systematic review'. Together they form a unique fingerprint.

Cite this